跳至主要内容
临床试验/ISRCTN17399068
ISRCTN17399068已完成2 期

A randomised controlled trial of high-flow nasal oxygen (Optiflow™) and standard oxygen therapy in high-risk patients after cardiac surgery

Papworth Hospital NHS Trust0 个研究点目标入组 74 人开始时间: 2015年7月16日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged over 18 years
  • 2. Undergoing elective cardiac surgery (coronary artery bypass grafting, valve surgery or both)
  • 3. One or more patient related risk factor for postoperative pulmonary complications (COPD, asthma, lower respiratory tract infection in last 4 weeks, body mass index=35 kg/m2 current (last 6 weeks) heavy smokers (> 10 pack years))
  • 4. Capable of performing a 6MWT. The 6MWT is a clinical exercise test, and is popular in clinical practice because it aids clinical decision making, and because of the belief that it provides a better estimate of functional capacity than resting cardiorespiratory measurements. The 6MWT is the most popular clinical exercise test, which is used for postoperative evaluation after lung surgery and has also been validated in cardiac surgery

排除标准

  • 1. Contraindication to high flow nasal oxygen such as nasal septal defect
  • 2. Not met extubation criteria by 10am the day after surgery (Day 1)
  • 3. Need for CPAP preoperatively

研究者

发起方
Papworth Hospital NHS Trust

相似试验

High-flow nasal oxygen (HFNO) in high-risk cardiac... | 临床试验